Human ehrlichioses

Medical Clinics of North America

Volumn 86, Issue 2, 2002, Pages 375-392

  Olano, Juan P ^a   Walker, David H ^a,b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; AMPICILLIN; AZITHROMYCIN; CHLORAMPHENICOL; CLARITHROMYCIN; DOXYCYCLINE HYCLATE; ERYTHROMYCIN; PENICILLIN G; TELITHROMYCIN; TETRACYCLINE;

CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; DRUG TOLERABILITY; EHRLICHIA CHAFFEENSIS; EHRLICHIOSIS; GEOGRAPHIC DISTRIBUTION; HUMAN; IMMUNOFLUORESCENCE; LABORATORY DIAGNOSIS; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SEROLOGY; SIDE EFFECT; SYMPTOM; TICK BORNE DISEASE; TREATMENT INDICATION; UNITED STATES;

EID: 0036230178     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7125(03)00093-2     Document Type: Review

References (93)

1. Identification of Ehrlichia spp. and Borrelia burgdorferi in Ixodes ticks in the Baltic Regions of Russia
2. Expression of a gene encoding the major antigenic protein 2 homolog of Ehrlichia chaffeensis and potential application for serodiagnosis
3. Detection of the etiologic agent of human ehrlichiosis by polymerase chain reaction
4. Exposure to deer blood may be a cause of human granulocytic ehrlichiosis
5. Clinical and laboratory characteristics of human granulocytic ehrlichiosis
6. Serological evidence of human granulocytic ehrlichiosis in Norway
7. Human granulocytic ehrlichiosis
8. Granulocytic ehrlichiosis in mice deficient in phagocyte oxidase or inducible nitric oxide synthase
9. Identifying human ehrlichiosis
10. Ehrlichia chaffeensis and E. sennetsu, but not the human granulocytic ehrlichiosis agent, colocalize with transferrin receptor and up-regulate transferrin receptor mRNA by activating iron-responsive protein 1
11. Clinical and epidemiological features of early Lyme disease and human granulocytic ehrlichiosis in Wisconsin
12. Novel Ehrlichia organism (rickettsiales: ehrlichiae) in white-tailed deer associated with Lone Star tick (Acari: Ixodidae) parasitism
13. Sequential evaluation of dogs naturally infected with Ehrlichia canis, Ehrlichia chaffeensis, Ehrlichia equi, Ehrlichia ewingii, or Bartonella vinsonii
14. In vitro antibiotic susceptibility of the newly recognized agent of ehrlichiosis in humans, Ehrlichia chaffeensis
15. Serologic evidence for human ehrlichiosis in Africa
16. Serologic diagnosis of human monocytic ehrlichiosis by immunoblot analysis
17. Diagnosis of granulocytic ehrlichiosis in humans by immunofluorescence assay
18. Ehrlichia ewingii, a newly recognized agent of human ehrlichiosis
19. Human granulocytic ehrlichiosis during pregnancy treated successfully with rifampin
20. Apoptosis of gamma/delta T cells in human ehrlichiosis
21. Identification of Ehrlichia chaffeensis by nested PCR in ticks from Southern China
22. Human granulocytic ehrlichiosis - New York, 1995
23. Identification of a granulocytotropic Ehrlichia species as the etiologic agent of human disease
24. Serologic testing for human granulocytic ehrlichiosis at a national referral center
25. Diagnosis of human ehrlichiosis by PCR assay of acute-phase serum
26. Isolation and characterization of an Ehrlichia spp. from a patient diagnosed with human ehrlichiosis
27. Human ehrlichiosis in the United States
28. Effect of tick removal on transmission of Borrelia burgdorferi and Ehrlichia phagocytophila by Ixodes scapularis nymphs
29. Human ehrlichiosis: Hematopathology and immunohistologic detection of Ehrlichia chaffeensis
30. Persistent infection with Ehrlichia chaffeensis
31. A population-based seroepidemiologic study of human granulocytic ehrlichiosis and Lyme borreliosis on the west coast of Sweden
32. Proposal for taxonomic reorganization of the order Rickettsiales, family Rickettsiaceae, and tribe Ehrlichieae
33. Serum cytokine responses during acute human granulocytic ehrlichiosis
34. Tick-borne ehrlichioses
35. Evaluation of an improved PCR diagnostic assay for human granulocytic ehrlichiosis
36. Human ehrlichiosis: Prospective active surveillance in febrile hospitalized patients
37. Human ehrlichiosis in the United States, 1985 to 1990
38. First case of human ehrlichiosis in Mexico
39. Direct cultivation of the causative agent of human granulocytic ehrlichiosis
40. Kinetics of serum antiplatelet antibodies in experimental acute canine ehrlichiosis
41. A single tissue culture system for the propagation of the agents of the human ehrlichioses
42. Intracellular parasitism by the human granulocytic ehrlichiosis bacterium through the P-selectin ligand, PSGL-1
43. Antimicrobial susceptibility of Ehrlichia phagocytophila
44. Detection of Ehrlichia chaffeensis DNA in Amblyomma americanum ticks in Connecticut and Rhode Island
45. Expression of interleukin-1β, tumor necrosis factor alpha, and interleukin-6 in human peripheral blood leukocytes exposed to human granulocytic ehrlichiosis agent or recombinant major surface protein P44
46. Antibiotic susceptibility of the newly cultivated agent of human granulocytic ehrlichiosis: Promising activity of quinolones and rifamycins
47. Detection of the agents of human ehrlichioses in Ixodid ticks from California
48. Anti-Ehrlichia chaffeensis antibody complexed with E. chaffeensis induces potent proinflammatory cytokine mRNA expression in human monocytes through sustained reduction of Iκ-B and activation of NF-κB
49. Protein kinase A-mediated inhibition of gamma interferon-induced tyrosine phosphorylation of Janus kinases and latent cytoplasmic transcription factors in human monocytes by Ehrlichia chaffeensis
50. Comparative pathology, and immunohistology associated with clinical illness after Ehrlichia phagocytophila-group infections
51. PCR detection of granulocytic ehrlichiae in Ixodes ricinus ticks and wild small mammals in western Switzerland
52. Isolation of Ehrlichia chaffeensis from wild white-tailed deer (Odocoileus virginianus) confirms their role as natural reservoir hosts
53. Human granulocytic ehrlichiosis in Europe: Clinical and laboratory findings for four patients from Slovenia
54. Human infection with Ehrlichia canis, a leukocytic rickettsia
55. Hemocytic rickettsia-like organisms in ticks: Serologic reactivity with antisera to ehrlichiae and detection of DNA of agent of human granulocytic ehrlichiosis by PCR
56. Pathology, immunohistology, and cytokine responses in early phases of human granulocytic ehrlichiosis in a murine model
57. Immunopathology and ehrlichial propagation are regulated by interferon-gamma and interleukin-10 in a murine model of human granulocytic ehrlichiosis
58. Survival of Ehrlichia chaffeensis in refrigerated, ADSOL-treated RBCs
59. The human ehrlichiosis in the United States
60. Human granulocytic ehrlichiosis agent and Ehrlichia chaffeensis reside in different cytoplasmic compartments in HL-60 cells
61. Human granulocytic ehrlichiosis agent inhibits superoxide anion generation by human neutrophils
62. Ehrlichial proliferation and acute hepatocellular necrosis in immunocompetent mice experimentally infected with the HF strain of Ehrlichia, closely related to Ehrlichia chaffeensis
63. Human monocytotropic ehrlichiosis (HME): Epidemiological, clinical and laboratory diagnosis of a newly emergent infection in the United States
64. First report of human granulocytic ehrlichiosis from Southern Europe (Spain)
65. Ixodes dammini as a potential vector of human granulocytic ehrlichiosis
66. Ehrlichia canis-like agent isolated from a man in Venezuela: Antigenic and genetic characterization
67. Human disease in Europe caused by a granulocytic Ehrlichia species
68. Identity of ehrlichial DNA sequences derived from Ixodes ricinus ticks with those obtained from patients with human granulocytic ehrlichiosis in Slovenia
69. Ultrastructural differentiation of the genogroups in the genus Ehrlichia
70. The 120 kDa outer membrane protein of Ehrlichia chaffeensis: Preferential expression on dense-core cells and gene expression in Escherichia coli associated with attachment and entry
71. Serological evidence of human granulocytic ehrlichiosis in Switzerland
72. Central nervous system manifestations of human ehrlichiosis
73. Isolation of the etiologic agent of human granulocytic ehrlichiosis from the white-footed mouse (Peromyscus leucopus)
74. Experimental transmission of Ehrlichia equi to horses through naturally infected ticks (Ixodes pacificus) from northern California
75. Evidence of rickettsial spotted fever and ehrlichial infections in a subtropical territory of Jujuy, Argentina
76. In vitro activities of telithromycin (HMR 3647) against Rickettsia rickettsii, Rickettsia conorii, Rickettsia africae, Rickettsia typhi, Rickettsia prowazekii, Coxiella burnetii, Bartonella henselae, Bartonella quintana, Bartonella bacilliformis, and Ehrlichia chaffeensis
77. Ehrlichia chaffeensis in Missouri ticks
78. Human monocytic ehrlichiosis in children
79. Animal model of fatal human monocytotropic ehrlichiosis
80. Primary isolation of Ehrlichia chaffeensis from patients with febrile illnesses: Clinical and molecular characteristics
81. PCR amplification and comparison of nucleotide sequences from the groESL heat shock operon of Ehrlichia species
82. Molecular cloning and characterization of the Ehrlichia chaffeensis variable-length PCR target: An antigen-expressing gene that exhibits interstrain variation
83. Comparison of two recombinant major outer membrane proteins of the human granulocytic ehrlichiosis agent for use in an enzyme-linked immunosorbent assay
84. Perpetuation of the agent of human granulocytic ehrlichiosis in a deer tick-rodent cycle
85. Western and dot blotting analyses of Ehrlichia chaffeensis indirect fluorescent-antibody assay-positive and -negative human sera by using native and recombinant E. chaffeensis and E. canis antigens
86. Human monocytic and granulocytic ehrlichioses: Discovery and diagnosis of emerging tick-borne infections and the critical role of the pathologist
87. Diagnosing human ehrlichioses: Current status and recommendations
88. Antibody-mediated elimination of the obligate intracellular bacterial pathogen Ehrlichia chaffeensis during active infection
89. Prevalence of Ehrlichia ewingii in Amblyomma americanum in North Carolina
90. Seroepidemiology of infections due to spotted fever group rickettsiae and Ehrlichia species in military personnel exposed to areas of the United States where such infections are endemic
91. Sequence and characterization of an Ehrlichia chaffeensis gene encoding 314 amino acids highly homologous to the NAD A enzyme
92. Comparison of Ehrlichia chaffeensis recombinant proteins for serologic diagnosis of human monocytotropic ehrlichiosis
93. Comparison of major antigenic proteins of six strains of the human granulocytic ehrlichiosis agent by western immunoblot analysis